HPV Vaccine for Men: Why It Matters, Who Benefits, and When to Get It

Understanding why HPV vaccination matters for men, who benefits most, and when vaccination is most effective is essential for making informed preventive health decisions. Why HPV Is Relevant for Men HPV is one of the most common sexually transmitted infections worldwide. Most sexually active men will be exposed to at least one HPV type at some point in their lives, often without ever knowing it.

While many infections clear on their own, some persist and can lead to disease. In men, persistent HPV infection is linked to cancers of the throat (oropharyngeal cancer), anus, penis, and to genital warts. In recent years, HPV-related throat cancers have become increasingly common in men, particularly in younger and middle-aged adults. Because men are less likely to have routine screening for HPV-related disease, infections often go undetected until symptoms appear.

This makes prevention through vaccination especially relevant. HPV vaccination also plays a role in reducing transmission. Vaccinated men are less likely to acquire and spread vaccine-covered HPV types, which contributes to broader community protection. Benefits of HPV Vaccination for Men The primary benefit of HPV vaccination in men is prevention. The vaccine reduces the risk of acquiring HPV types associated with genital warts and HPV-related cancers.

This protection applies whether or not a man ever develops symptoms. Vaccination can also reduce the likelihood of transmitting HPV to sexual partners. While HPV vaccination is not a substitute for other preventive measures, lowering transmission risk has public-health benefits, particularly in populations with lower vaccination coverage. Another important benefit is that HPV vaccination does not rely on behavioural assumptions.

HPV exposure can occur regardless of relationship status, sexual orientation, or perceived risk. Vaccination provides protection that does not depend on predicting future exposure. For men who may later develop HPV-related disease, prevention can also reduce the need for invasive treatments, which can have long-term physical and psychological effects. Ideal Age for HPV Vaccination in Men The HPV vaccine is most effective when given before exposure to the virus, which is why vaccination is recommended during early adolescence.

In boys, vaccination can be started from around nine years of age, similar to girls. At younger ages, the immune response to the vaccine is strong, and fewer doses are typically required. Vaccinating before sexual debut maximises protection against future HPV exposure. However, HPV vaccination is not limited to adolescents. Adult men can still benefit from vaccination because HPV includes multiple virus types, and most people are not exposed to all of them.

There is no strict upper age limit beyond which HPV vaccination is considered ineffective. Instead, decisions are usually individualised, based on age, health status, and personal risk factors. Trends in HPV Vaccination Among Men Globally, HPV vaccination programmes initially focused on girls, but many countries have since adopted gender-neutral vaccination policies. This shift reflects growing recognition of HPV-related disease burden in men and the role of vaccination in reducing overall transmission.

Countries that introduced routine HPV vaccination for boys have reported rising uptake and increasing public awareness of HPV risks in men. Over time, this has been associated with declines in genital warts and early indicators of reduced HPV infection in male populations. In India, awareness of HPV vaccination in men remains limited, but interest has been increasing, particularly among urban populations and individuals seeking preventive healthcare.

As information improves and stigma decreases, HPV vaccination in men is likely to follow a similar trajectory to other preventive health measures that were once under-utilised.

Frequently Asked Questions